Market Research Reports and Industry Reports

Nerve Injury - Pipeline Review, H2 2015

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

Summary
 
 Global Markets Direct’s, ‘Nerve Injury - Pipeline Review, H2 2015’, provides an overview of the Nerve Injury’s therapeutic pipeline.
 
 This report provides comprehensive information on the therapeutic development for Nerve Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nerve Injury and special features on late-stage and discontinued projects.
 
 Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
 
 The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
 
 Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 
 Scope
 
 - The report provides a snapshot of the global therapeutic landscape of Nerve Injury
 - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
 - The report reviews key players involved in the therapeutics development for Nerve Injury and enlists all their major and minor projects
 - The report summarizes all the dormant and discontinued pipeline projects
 - A review of the Nerve Injury products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
 - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
 - A detailed assessment of monotherapy and combination therapy pipeline projects
 - Coverage of the Nerve Injury pipeline on the basis of target, MoA, route of administration and molecule type
 - Latest news and deals relating related to pipeline products
 
 Reasons to buy
 
 - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
 - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
 - Develop strategic initiatives by understanding the focus areas of leading companies
 - Identify and understand important and diverse types of therapeutics under development for Nerve Injury
 - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
 - Devise corrective measures for pipeline projects by understanding Nerve Injury pipeline depth and focus of Indication therapeutics
 - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
 - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

 Table of Contents 2
 List of Tables 4
 List of Figures 4
 Introduction 5
 Global Markets Direct Report Coverage 5
 Nerve Injury Overview 6
 Therapeutics Development 7
 Pipeline Products for Nerve Injury - Overview 7
 Pipeline Products for Nerve Injury - Comparative Analysis 8
 Nerve Injury - Therapeutics under Development by Companies 9
 Nerve Injury - Therapeutics under Investigation by Universities/Institutes 10
 Nerve Injury - Pipeline Products Glance 11
 Clinical Stage Products 11
 Early Stage Products 12
 Nerve Injury - Products under Development by Companies 13
 Nerve Injury - Products under Investigation by Universities/Institutes 14
 Nerve Injury - Companies Involved in Therapeutics Development 15
 Acorda Therapeutics, Inc. 15
 Calico LLC 16
 F. Hoffmann-La Roche Ltd. 17
 Human Stem Cells Institute 18
 Kolon Life Science, Inc. 19
 Neuralstem, Inc. 20
 Neurotune AG 21
 Nerve Injury - Therapeutics Assessment 22
 Assessment by Monotherapy Products 22
 Assessment by Target 23
 Assessment by Mechanism of Action 25
 Assessment by Route of Administration 27
 Assessment by Molecule Type 29
 Drug Profiles 31
 3K3A-APC - Drug Profile 31
 Product Description 31
 Mechanism of Action 31
 R&D Progress 31
 ACTX-07 - Drug Profile 33
 Product Description 33
 Mechanism of Action 33
 R&D Progress 33
 cimaglermin alfa - Drug Profile 34
 Product Description 34
 Mechanism of Action 34
 R&D Progress 34
 CLP-257 - Drug Profile 36
 Product Description 36
 Mechanism of Action 36
 R&D Progress 36
 Gene Therapy to Activate Vascular Endothelial Growth Factor for Cardiovascular Disease and Central Nervous System Disorders - Drug Profile 37
 Product Description 37
 Mechanism of Action 37
 R&D Progress 37
 KLS-Nst - Drug Profile 38
 Product Description 38
 Mechanism of Action 38
 R&D Progress 38
 NSI-566 - Drug Profile 39
 Product Description 39
 Mechanism of Action 39
 R&D Progress 39
 NT-1654 - Drug Profile 41
 Product Description 41
 Mechanism of Action 41
 R&D Progress 41
 Small Molecules to Activate NAMPT for Neurological Disorders - Drug Profile 42
 Product Description 42
 Mechanism of Action 42
 R&D Progress 42
 Synthetic Peptides to Inhibit PDE-4A4 for Pulmonary Fibrosis and Nerve Injury - Drug Profile 43
 Product Description 43
 Mechanism of Action 43
 R&D Progress 43
 Nerve Injury - Recent Pipeline Updates 44
 Nerve Injury - Dormant Projects 53
 Nerve Injury - Discontinued Products 54
 Appendix 55
 Methodology 55
 Coverage 55
 Secondary Research 55
 Primary Research 55
 Expert Panel Validation 55
 Contact Us 55
 Disclaimer 56


List Of Tables

 Number of Products under Development for Nerve Injury, H2 2015 7
 Number of Products under Development for Nerve Injury - Comparative Analysis, H2 2015 8
 Number of Products under Development by Companies, H2 2015 9
 Number of Products under Investigation by Universities/Institutes, H2 2015 10
 Comparative Analysis by Clinical Stage Development, H2 2015 11
 Comparative Analysis by Early Stage Development, H2 2015 12
 Products under Development by Companies, H2 2015 13
 Products under Investigation by Universities/Institutes, H2 2015 14
 Nerve Injury - Pipeline by Acorda Therapeutics, Inc., H2 2015 15
 Nerve Injury - Pipeline by Calico LLC, H2 2015 16
 Nerve Injury - Pipeline by F. Hoffmann-La Roche Ltd., H2 2015 17
 Nerve Injury - Pipeline by Human Stem Cells Institute, H2 2015 18
 Nerve Injury - Pipeline by Kolon Life Science, Inc., H2 2015 19
 Nerve Injury - Pipeline by Neuralstem, Inc., H2 2015 20
 Nerve Injury - Pipeline by Neurotune AG, H2 2015 21
 Assessment by Monotherapy Products, H2 2015 22
 Number of Products by Stage and Target, H2 2015 24
 Number of Products by Stage and Mechanism of Action, H2 2015 26
 Number of Products by Stage and Route of Administration, H2 2015 28
 Number of Products by Stage and Molecule Type, H2 2015 30
 Nerve Injury Therapeutics - Recent Pipeline Updates, H2 2015 44
 Nerve Injury - Dormant Projects, H2 2015 53
 Nerve Injury - Discontinued Products, H2 2015 54


List Of Figures

 Number of Products under Development for Nerve Injury, H2 2015 7
 Number of Products under Development for Nerve Injury - Comparative Analysis, H2 2015 8
 Number of Products under Development by Companies, H2 2015 9
 Comparative Analysis by Early Stage Products, H2 2015 12
 Assessment by Monotherapy Products, H2 2015 22
 Number of Products by Top 10 Targets, H2 2015 23
 Number of Products by Stage and Top 10 Targets, H2 2015 23
 Number of Products by Top 10 Mechanism of Actions, H2 2015 25
 Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 25
 Number of Products by Top 10 Routes of Administration, H2 2015 27
 Number of Products by Stage and Top 10 Routes of Administration, H2 2015 27
 Number of Products by Top 10 Molecule Types, H2 2015 29
 Number of Products by Stage and Top 10 Molecule Types, H2 2015 29


China Vagus Nerve Stimulators Market Research Report 2016

Notes:Sales, means the sales volume of Vagus Nerve StimulatorsRevenue, means the sales value of Vagus Nerve StimulatorsThis report studies Vagus Nerve Stimulators in China market, focuses on the top players

USD 3200View Report

United States Vagus Nerve Stimulators Market Report 2016

Notes:Sales, means the sales volume of Vagus Nerve StimulatorsRevenue, means the sales value of Vagus Nerve StimulatorsThis report studies sales (consumption) of Vagus Nerve Stimulators in United States market, focuses

USD 3800View Report

EnerVest, Ltd Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

EnerVest, Ltd Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile, future

USD 200View Report

Spinal Cord Injury - Pipeline Review, H2 2016

Spinal Cord Injury - Pipeline Review, H2 2016Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Spinal Cord Injury Pipeline Review, H2 2016, provides an overview of the

USD 2000View Report

Traumatic Brain Injury - Epidemiology Forecast To 2023

DelveInsight Traumatic Brain Injury - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Traumatic Brain Injury in seven major markets (US, France, Germany, Italy, Spain, UK

USD 2750View Report

Ischemia Reperfusion Injury - Pipeline Review, H2 2016

Ischemia Reperfusion Injury - Pipeline Review, H2 2016Global Markets Directs, Ischemia Reperfusion Injury - Pipeline Review, H2 2016, provides an overview of the Ischemia Reperfusion Injury pipeline landscape. The report

USD 2000View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF    $ 2000
  • Site Licence    $ 4000
  • Enterprise Wide Licence    $ 6000
$ 2000

Reports Details

Published Date : Jul 2015
No. of Pages :56
Country :Global
Category :Healthcare
Publisher :Global Markets Direct
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment